SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19306417
Source:
http://linkedlifedata.com/resource/pubmed/id/19306417
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013216
,
umls-concept:C0032207
,
umls-concept:C0038952
,
umls-concept:C0042149
,
umls-concept:C0334359
,
umls-concept:C0441766
,
umls-concept:C1274040
,
umls-concept:C1522449
pubmed:issue
10
pubmed:dateCreated
2009-5-4
pubmed:abstractText
A study was undertaken to determine recurrence patterns and survival outcomes of stage I uterine papillary serous carcinoma (UPSC) patients.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19306417-19452535
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Bridged Compounds
,
http://linkedlifedata.com/resource/pubmed/chemical/Platinum
,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids
,
http://linkedlifedata.com/resource/pubmed/chemical/taxane
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0008-543X
pubmed:author
pubmed-author:AxtellAllison EAE
,
pubmed-author:DrakeRichard DRD
,
pubmed-author:FaderAmanda NicklesAN
,
pubmed-author:GehrigPaola APA
,
pubmed-author:GibbonsHeidi EHE
,
pubmed-author:HavrileskyLaura JLJ
,
pubmed-author:HuhWarner KWK
,
pubmed-author:O'MalleyDavid MDM
,
pubmed-author:TullerErinE
,
pubmed-author:Uterine Papillary Serous Carcinoma (UPSC) Consortium
,
pubmed-author:ZanottiKristine MKM
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
115
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2119-27
pubmed:dateRevised
2009-9-2
pubmed:meshHeading
pubmed-meshheading:19306417-Aged
,
pubmed-meshheading:19306417-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:19306417-Bridged Compounds
,
pubmed-meshheading:19306417-Combined Modality Therapy
,
pubmed-meshheading:19306417-Cystadenocarcinoma, Papillary
,
pubmed-meshheading:19306417-Disease-Free Survival
,
pubmed-meshheading:19306417-Female
,
pubmed-meshheading:19306417-Humans
,
pubmed-meshheading:19306417-Platinum
,
pubmed-meshheading:19306417-Recurrence
,
pubmed-meshheading:19306417-Retrospective Studies
,
pubmed-meshheading:19306417-Taxoids
,
pubmed-meshheading:19306417-Uterine Neoplasms
pubmed:year
2009
pubmed:articleTitle
Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.
pubmed:affiliation
Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, Ohio, USA. amanditan@yahoo.com
pubmed:publicationType
Journal Article
,
Multicenter Study